Upgrade to SI Premium - Free Trial

Sarepta Therapeutics (SRPT) PT Raised to $50 at Wells Fargo

August 7, 2025 5:47 AM
Wells Fargo analyst Yanan Zhu raised the price target on Sarepta Therapeutics (NASDAQ: SRPT) to $50.00 (from $48.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles